Narrow search
Showing 1 - 10 of 9,182
Cover Image
Technology choice, adaptation, and diffusion in privately and state-owned enterprises in India.
AB, Deolalikar; Sundaram, A. K - International Labour Organization (ILO), United Nations - 1985
heavy electrical industry firms, compares organization behaviour, management decision making, Innovation research and …
Persistent link: https://www.econbiz.de/10010966481
Cover Image
The Sectoral system of innovation of Indian pharmaceutical industry
Mani, Sunil - Centre for Development Studies (CDS) - 2006
The paper undertakes a detailed mapping out of the sectoral system of innovation of India's pharmaceutical industry …. The industry is one of the most innovative industries in the Indian manufacturing sector. The innovation system of the … right, strong government research institutes and private sector enterprises which have invested in innovation. The TRIPS …
Persistent link: https://www.econbiz.de/10010860091
Cover Image
The relationship of drug reimbursement with the price and the quality of pharmaceutical innovations
García-Alonso, M. D. C.; Mariñoso, B. G. - Department of Economics, City University - 2005
This paper studies the strategic interaction between pharmaceutical firms' pricing decisions and government agencies' reimbursement decisions which discriminate between patients by giving reimbursement rights to patients for whom the drug is most effective. We show that if the reimbursement...
Persistent link: https://www.econbiz.de/10011268904
Cover Image
China's Pharmaceutical Industry: Typologies and Characteristics
Zhang, Hayan - eSocialSciences - 2006
This paper uses aggregate and firm level data to examine the characteristics of the Chinese pharmaceutical industry in general and its geographical agglomeration in particular. It addresses the following research questions: 1) Are there geographical agglomerations in China’s...
Persistent link: https://www.econbiz.de/10005341674
Cover Image
R&D and financial systems: the determinants of R&D expenditures in the Swedish pharmaceutical industry
Malmberg, Claes - Centre for Innovation, Research and Competence in the … - 2008
This study investigates the determinants of R&D expenditures in the Swedish pharmaceutical industry from the 1960s to the mid 1990s. Various proxies for the rate of return of R&D (e.g. expected profit, sales and R&D productivity) as well as the availability of internal funding (proxied by past...
Persistent link: https://www.econbiz.de/10005077278
Cover Image
Corporate Governance and the Governance of Innovation: the Case of Pharmaceutical Industry
Lacetera, Nicola - KITeS, Centre for Knowledge, Internationalization and … - 2000
literature on firm's boundaries and sectoral systems of innovation, we propose industry-specific variables for pharmaceuticals …
Persistent link: https://www.econbiz.de/10005087157
Cover Image
Breaking the Fence: Patent Rights and Biomedical Innovation in 'Technology Followers'
Gehl Sampath, Padmashree - United Nations University, Maastricht Economic and … - 2006
The impact of patent protection on biomedical innovation has been a controversial issue. Although a "medical anti … difficult to predict the impact of patenting on biomedical innovation in developing and least developed countries. This paper … develops a framework of analysis for the impact of patent rights on biomedical innovation in "technology follower" developing …
Persistent link: https://www.econbiz.de/10005150790
Cover Image
INNOVATIVE CAPABILITY DEVELOPMENT IN THE INDIAN PHARMACEUTICAL INDUSTRY
KALE, DINAR - In: International Journal of Innovation and Technology … 09 (2012) 02, pp. 1250013-1
With increasing globalization, firms in emerging countries are facing turbulent business environment that is marked by liberalization of economic policies and regulatory changes. In such cases firms have to undertake dynamic learning to develop new capability. In developing countries the...
Persistent link: https://www.econbiz.de/10010556606
Cover Image
Market failure in the pharmaceutical industry and how it can be overcome: the CureShare mechanism
Levy, Moshe; Rizansky, Adi - In: The European Journal of Health Economics 15 (2014) 2, pp. 143-156
Allowing patients to take part in the initial investment for the development of cures for their illnesses can, under certain conditions, lead to the development of drugs that would have otherwise not been developed and to a dramatic welfare increase. We theoretically analyze these conditions....
Persistent link: https://www.econbiz.de/10010845776
Cover Image
Market size and innovation: Effects of Medicare Part D on pharmaceutical research and development
Blume-Kohout, Margaret E.; Sood, Neeraj - In: Journal of Public Economics 97 (2013) C, pp. 327-336
innovation. This paper assesses the impact of the Medicare Part D legislation on pharmaceutical research and development (R …
Persistent link: https://www.econbiz.de/10010608550